699 related articles for article (PubMed ID: 33198260)
21. Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology.
Shriver SP; Adams D; McKelvey BA; McCune JS; Miles D; Pratt VM; Ashcraft K; McLeod HL; Williams H; Fleury ME
J Clin Oncol; 2024 Apr; 42(10):1181-1192. PubMed ID: 38386947
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of predicted gene-drug interactions for antidepressants in the treatment of major depressive disorder in the Precision Medicine in Mental Health Care Study.
Ramsey CM; Lynch KG; Thase ME; Gelernter J; Kranzler HR; Pyne JM; Shih MC; Stone A; ; Oslin DW
J Affect Disord; 2021 Mar; 282():1272-1277. PubMed ID: 33601706
[TBL] [Abstract][Full Text] [Related]
23. An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean.
Salas-Hernández A; Galleguillos M; Carrasco M; López-Cortés A; Redal MA; Fonseca-Mendoza D; Esperón P; González-Martínez F; Lares-Asseff I; Lazarowski A; Loera-Castañeda V; Remírez D; Martínez MF; Vargas R; Rios-Santos F; Macho A; Cayún JP; Perez GR; Gutierrez C; Cerpa LC; Leiva T; Calfunao S; Xajil L; Sandoval C; Suárez M; Gonzalez A; Echeverría-Garcés G; Sullón-Dextre L; Cordero-García E; Morales AR; Avendaño A; Sánchez E; Bastone LC; Lara C; Zuluaga-Arias P; Soler AM; Da Luz J; Burgueño-Rodríguez G; Vital M; Reyes-Reyes E; Huaccha A; Ariza YV; Tzul N; Rendón AL; Serrano R; Acosta L; Motta-Pardo A; Beltrán-Angarita L; Brand E; Jiménez MA; Hidalgo-Lozada GM; Romero-Prado MMJ; Escobar-Castro K; Umaña-Rivas M; Vivas JD; Lagos P; Martínez YB; Quesada S; Calfio C; Arias ML; Lavanderos MA; Cáceres DD; Salazar-Granara A; Varela NM; Quiñones LA
Front Pharmacol; 2023; 14():1175737. PubMed ID: 37251329
[TBL] [Abstract][Full Text] [Related]
24. A systematic review and meta-analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer.
Lingaratnam S; Shah M; Nicolazzo J; Michael M; Seymour JF; James P; Lazarakis S; Loi S; Kirkpatrick CMJ
Clin Transl Sci; 2024 May; 17(5):e13781. PubMed ID: 38700261
[TBL] [Abstract][Full Text] [Related]
25. The Role of Pharmacogenomics in Opioid Prescribing.
Wong AK; Somogyi AA; Rubio J; Philip J
Curr Treat Options Oncol; 2022 Oct; 23(10):1353-1369. PubMed ID: 36001223
[TBL] [Abstract][Full Text] [Related]
26. Implementation of Pharmacogenomics in Everyday Clinical Settings.
Bank PCD; Swen JJ; Guchelaar HJ
Adv Pharmacol; 2018; 83():219-246. PubMed ID: 29801576
[TBL] [Abstract][Full Text] [Related]
27. Implementing comprehensive pharmacogenomics in a community hospital-associated primary care setting.
Wick JA; Schmidlen T; Grande K; Moretz C; Ashcraft K; Green J; Moyer N; Blaxall BC
J Am Pharm Assoc (2003); 2023; 63(1):188-192. PubMed ID: 36243653
[TBL] [Abstract][Full Text] [Related]
28. What Are the Barriers and Enablers to the Implementation of Pharmacogenetic Testing in Mental Health Care Settings?
Jameson A; Fylan B; Bristow GC; Sagoo GS; Dalton C; Cardno A; Sohal J; McLean SL
Front Genet; 2021; 12():740216. PubMed ID: 34630531
[TBL] [Abstract][Full Text] [Related]
29. Effect of pharmacogenomic testing on pharmacotherapy decision making in patients with symptoms of depression in an interprofessional primary care clinic.
Roscizewski L; Henneman A; Snyder T
J Am Pharm Assoc (2003); 2022; 62(2):569-574.e1. PubMed ID: 34801407
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenomics and tailored polypharmacy: an 80-year-old lady with rosuvastatin-associated rhabdomyolysis and maprotiline-related Ogilvie's syndrome
.
Sreter KB; Barisic B; Popovic-Grle S
Int J Clin Pharmacol Ther; 2017 May; 55(5):442-448. PubMed ID: 28257284
[TBL] [Abstract][Full Text] [Related]
32. Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-
Kisor DF; Petry NJ; Bright DR
Pharmgenomics Pers Med; 2021; 14():569-577. PubMed ID: 34040417
[TBL] [Abstract][Full Text] [Related]
33. Using Pharmacogenomic Testing in Primary Care: Protocol for a Pilot Randomized Controlled Study.
Manzor Mitrzyk B; Kadri R; Farris KB; Ellingrod VL; Klinkman MS; Ruffin Iv MT; Plegue MA; Buis LR
JMIR Res Protoc; 2019 Aug; 8(8):e13848. PubMed ID: 31429417
[TBL] [Abstract][Full Text] [Related]
34. Minimising Adverse Drug Reactions and Verifying Economic Legitimacy-Pharmacogenomics Implementation in Children (MARVEL- PIC): protocol for a national randomised controlled trial of pharmacogenomics implementation.
Conyers R; Halman A; Moore C; Stenta T; Felmingham B; Collier L; Khatri D; Spelman T; Williams E; Dyas R; Kotecha RS; Jessop S; Mateos MK; Swen J; Elliott DA
BMJ Open; 2024 May; 14(5):e085115. PubMed ID: 38760050
[TBL] [Abstract][Full Text] [Related]
35. Lack of exposure to pharmacogenomics education among the health care providing students in the West Bank of Palestine.
Jarrar Y; Musleh R; Hamdan A; Ghanim M; Alqub M; Abudahab S
Drug Metab Pers Ther; 2023 Sep; 38(3):267-272. PubMed ID: 36913309
[TBL] [Abstract][Full Text] [Related]
36. Using pharmacogenetics in primary care.
Murfin M
JAAPA; 2019 Aug; 32(8):17-21. PubMed ID: 31290773
[TBL] [Abstract][Full Text] [Related]
37. Providers' Use of Pharmacogenetic Testing to Inform Antidepressant Prescribing: Results of Qualitative Interviews.
Vest BM; Wray LO; Thase ME; Brady LA; Chapman SR; Oslin DW
Psychiatr Serv; 2023 Dec; 74(12):1270-1276. PubMed ID: 37528698
[TBL] [Abstract][Full Text] [Related]
38. Pharmacogenomics research and clinical implementation in Brazil.
Rodrigues-Soares F; Suarez-Kurtz G
Basic Clin Pharmacol Toxicol; 2019 May; 124(5):538-549. PubMed ID: 30589990
[TBL] [Abstract][Full Text] [Related]
39. Potentially actionable pharmacogenetic variants and symptom control medications in oncology.
Patel JN; Boselli D; Jandrisevits EJ; Hamadeh IS; Salem A; Meadors P; Walsh D
Support Care Cancer; 2021 Oct; 29(10):5927-5934. PubMed ID: 33758969
[TBL] [Abstract][Full Text] [Related]
40. An Investigation of the Knowledge Overlap between Pharmacogenomics and Disease Genetics.
Li B; Whirl-Carrillo M; Wright MW; Babb L; Rehm HL; Klein TE
Pac Symp Biocomput; 2022; 27():385-396. PubMed ID: 34890165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
